Thrombosis [clinicaltrials_resource:ca72716517fa5df21bb9a6b9cf3f47b7]
Postmenopausal Estrogen/Progestin Interventions (PEPI) [clinicaltrials:NCT00000466]Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA) [clinicaltrials:NCT00000538]A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters [clinicaltrials:NCT00001518]The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A [clinicaltrials:NCT00004564]Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) [clinicaltrials:NCT00005260]Novel Hemostatic Cardiac Risk Factors in Framingham [clinicaltrials:NCT00005356]Thrombogenic Factors and Recurrent Coronary Events [clinicaltrials:NCT00005358]Lupus Cohort--Thrombotic Events and Coronary Artery Disease [clinicaltrials:NCT00005436]Inflammation Markers Over Time in Cardiovascular Disease [clinicaltrials:NCT00005692]Genetic Architecture of Plasma T-PA and PAI-1 [clinicaltrials:NCT00007410]Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices [clinicaltrials:NCT00039767]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D [clinicaltrials:NCT00041405]Study Of Angiomax In Infants Under Six Months With Thrombosis [clinicaltrials:NCT00043277]Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [clinicaltrials:NCT00043940]Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA [clinicaltrials:NCT00046605]Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins [clinicaltrials:NCT00055159]Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion [clinicaltrials:NCT00073554]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00107900clinicaltrials:NCT00143715Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters [clinicaltrials:NCT00157651]Long Study - Longitudinal Thrombosis in End Stage Renal Disease [clinicaltrials:NCT00157664]Epidemiology Study in Major Orthopaedic Surgery [clinicaltrials:NCT00159185]STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery [clinicaltrials:NCT00190307]Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [clinicaltrials:NCT00203580]Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [clinicaltrials:NCT00203658]Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services [clinicaltrials:NCT00203970]Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery [clinicaltrials:NCT00237328]clinicaltrials:NCT00265005Alteplase for Blood Flow Restoration in Hemodialysis Catheters [clinicaltrials:NCT00303420]Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) [clinicaltrials:NCT00311896]A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer [clinicaltrials:NCT00320255]Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters [clinicaltrials:NCT00322270]Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion [clinicaltrials:NCT00336596]clinicaltrials:NCT00345618Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters [clinicaltrials:NCT00346424]Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries [clinicaltrials:NCT00352222]The Association of Platelet Function and Endothelial Function of the Brachial Artery [clinicaltrials:NCT00363818]clinicaltrials:NCT00379366
condition [clinicaltrials_vocabulary:condition]
Epidemiology of Venous Thrombosis and Pulmonary Embolism [clinicaltrials:NCT00005504]Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis [clinicaltrials:NCT00005684]Risk Factors for Venous Thromboembolism [clinicaltrials:NCT00018772]clinicaltrials:NCT00038961Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices [clinicaltrials:NCT00039767]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D [clinicaltrials:NCT00041405]Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients [clinicaltrials:NCT00041782]Study Of Angiomax In Infants Under Six Months With Thrombosis [clinicaltrials:NCT00043277]Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [clinicaltrials:NCT00043940]Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins [clinicaltrials:NCT00055159]Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) [clinicaltrials:NCT00067093]SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis [clinicaltrials:NCT00071279]The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study [clinicaltrials:NCT00071903]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00082355BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [clinicaltrials:NCT00097357]clinicaltrials:NCT00107900Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot [clinicaltrials:NCT00114608]Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) [clinicaltrials:NCT00119457]Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis [clinicaltrials:NCT00123734]clinicaltrials:NCT00143598clinicaltrials:NCT00143715MDA D-Dimer / Recurrent DVT Study [clinicaltrials:NCT00157599]Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters [clinicaltrials:NCT00157651]Long Study - Longitudinal Thrombosis in End Stage Renal Disease [clinicaltrials:NCT00157664]clinicaltrials:NCT00157677Evaluation of Hemostasis in Bleeding and Thrombotic Disorders [clinicaltrials:NCT00178594]Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis [clinicaltrials:NCT00178789]D-Dimer and IPG for Recurrent Thrombosis (DIRECT) [clinicaltrials:NCT00182247]D-Dimer Vs Serial Compression Ultrasound Study [clinicaltrials:NCT00182351]PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [clinicaltrials:NCT00182364]Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) [clinicaltrials:NCT00182546]Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure [clinicaltrials:NCT00186745]The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [clinicaltrials:NCT00187408]Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [clinicaltrials:NCT00203580]Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [clinicaltrials:NCT00203658]Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services [clinicaltrials:NCT00203970]A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) [clinicaltrials:NCT00211146]The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis [clinicaltrials:NCT00216866]
condition browse [clinicaltrials_vocabulary:condition-browse]
Epidemiology of Venous Thrombosis and Pulmonary Embolism [clinicaltrials:NCT00005504]Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis [clinicaltrials:NCT00005684]Risk Factors for Venous Thromboembolism [clinicaltrials:NCT00018772]clinicaltrials:NCT00038961Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices [clinicaltrials:NCT00039767]Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin [clinicaltrials:NCT00039858]Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D [clinicaltrials:NCT00041405]Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients [clinicaltrials:NCT00041782]Study Of Angiomax In Infants Under Six Months With Thrombosis [clinicaltrials:NCT00043277]Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) [clinicaltrials:NCT00043940]Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins [clinicaltrials:NCT00055159]Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) [clinicaltrials:NCT00067093]SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis [clinicaltrials:NCT00071279]The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study [clinicaltrials:NCT00071903]Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [clinicaltrials:NCT00073580]clinicaltrials:NCT00082355BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [clinicaltrials:NCT00097357]clinicaltrials:NCT00107900Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot [clinicaltrials:NCT00114608]Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) [clinicaltrials:NCT00119457]Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis [clinicaltrials:NCT00123734]clinicaltrials:NCT00143598clinicaltrials:NCT00143715MDA D-Dimer / Recurrent DVT Study [clinicaltrials:NCT00157599]Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters [clinicaltrials:NCT00157651]Long Study - Longitudinal Thrombosis in End Stage Renal Disease [clinicaltrials:NCT00157664]clinicaltrials:NCT00157677Evaluation of Hemostasis in Bleeding and Thrombotic Disorders [clinicaltrials:NCT00178594]Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis [clinicaltrials:NCT00178789]D-Dimer and IPG for Recurrent Thrombosis (DIRECT) [clinicaltrials:NCT00182247]D-Dimer Vs Serial Compression Ultrasound Study [clinicaltrials:NCT00182351]PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [clinicaltrials:NCT00182364]Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) [clinicaltrials:NCT00182546]Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure [clinicaltrials:NCT00186745]The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [clinicaltrials:NCT00187408]Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [clinicaltrials:NCT00203580]Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [clinicaltrials:NCT00203658]Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services [clinicaltrials:NCT00203970]A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) [clinicaltrials:NCT00211146]The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis [clinicaltrials:NCT00216866]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Thrombosis [clinicaltrials_resource:ca72716517fa5df21bb9a6b9cf3f47b7]
Bio2RDF identifier
ca72716517fa5df21bb9a6b9cf3f47b7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ca72716517fa5df21bb9a6b9cf3f47b7
identifier
clinicaltrials_resource:ca72716517fa5df21bb9a6b9cf3f47b7
title
Thrombosis
@en
type
label
Thrombosis [clinicaltrials_resource:ca72716517fa5df21bb9a6b9cf3f47b7]
@en
Thrombosis